• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

NAACOS Submits Comments to CMS Regarding International Pricing Index Model

Article

The National Association of Accountable Care Organizations (NAACOS) has submitted commented to CMS in response to the proposed International Pricing Index Model for Medicare Part B Drugs.

The National Association of Accountable Care Organizations (NAACOS) has submitted commented to CMS in response to the proposed International Pricing Index Model for Medicare Part B Drugs. Writing to CMS Administrator Seema Verma, the association said they appreciate CMS' efforts to lower drug prices as Medicare Part B drug spending has increased approximately 10% each year since 2011.

However, they also write that the proposal includes a number of unanswered questions about how the proposed model affects ACOs, which must be addressed before moving forward. They include recommendations on how CMS can address Part B drug costs while working with the Medicare Shared Savings Program and other ACO programs. Read the full comments and recommendations.

Related Videos
Dr Christina Poh
Rakendu Rajendran, MBBS
Vivek Bhalla, MD, Stanford University School of Medicine
Rayan Salih, MD, Northeast Georgia Health System
Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, Mount Sinai Fuster Heart Hospital
Varsha Tanguturi, MD, MPH, Mass General Hospital
 Khush Kharidia, MD, UT Southwestern
Alexandra M. Trevino, MD, Northwestern Medicine
Nicole Bajic, MD
Dr Sundar Jagannath
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.